investorscraft@gmail.com

Intrinsic Value of Tabula Rasa Healthcare (TRHC)

Previous Close$0.00
Intrinsic Value
Upside potential
Previous Close
$0.00
* Our model cannot be used “out of the box” for the valuation of this stock. You can still do your own valuation by changing the valuation input parameters.

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2022-12-31 and quarterly data as of 2023-06-30.

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year(a)2023202420252026202720282029203020312032203320342035203620372038203920402041204220432044204520462047

INCOME STATEMENT

Revenue growth rate, %15.3NaN
Revenue, $300NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m368NaN
Operating income, $m-69NaN
EBITDA, $m-36NaN
Interest expense (income), $mNaN
Earnings before tax, $m-147NaN
Tax expense, $m0NaN
Net income, $m-148NaN

BALANCE SHEET

Cash and short-term investments, $m82NaN
Total assets, $m384NaN
Adjusted assets (=assets-cash), $m302NaN
Average production assets, $m168NaN
Working capital, $m68NaN
Total debt, $m324NaN
Total liabilities, $m441NaN
Total equity, $m-57NaN
Debt-to-equity ratio-5.680NaN
Adjusted equity ratio-0.451NaN

CASH FLOW

Net income, $m-148NaN
Depreciation, amort., depletion, $m33NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m7NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-29NaN
Free cash flow, $m36NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m68
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount